Alaska Permanent Fund Corp Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Alaska Permanent Fund Corp acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, Holdings Channel.com reports. The fund acquired 8,058 shares of the healthcare conglomerate’s stock, valued at approximately $4,242,000.

Several other hedge funds have also modified their holdings of UNH. Bray Capital Advisors grew its stake in shares of UnitedHealth Group by 0.5% during the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after purchasing an additional 50 shares during the last quarter. Trust Co. of Oklahoma acquired a new position in UnitedHealth Group in the third quarter valued at approximately $441,000. Kraft Davis & Associates LLC raised its holdings in UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after purchasing an additional 19 shares during the period. Naples Global Advisors LLC raised its holdings in shares of UnitedHealth Group by 0.8% during the third quarter. Naples Global Advisors LLC now owns 12,445 shares of the healthcare conglomerate’s stock worth $6,274,000 after acquiring an additional 98 shares during the period. Finally, Bluesphere Advisors LLC raised its stake in UnitedHealth Group by 10.9% in the 3rd quarter. Bluesphere Advisors LLC now owns 2,614 shares of the healthcare conglomerate’s stock worth $1,318,000 after purchasing an additional 256 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 0.2 %

UnitedHealth Group stock traded up $1.12 during mid-day trading on Wednesday, reaching $487.30. The stock had a trading volume of 3,722,294 shares, compared to its average volume of 4,532,979. The company has a 50-day moving average price of $487.49 and a two-hundred day moving average price of $514.76. The company has a market capitalization of $449.26 billion, a price-to-earnings ratio of 29.48, a PEG ratio of 1.42 and a beta of 0.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period last year, the firm posted $6.26 EPS. The company’s revenue was up 8.6% on a year-over-year basis. On average, analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Truist Financial restated a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Piper Sandler upped their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Bank of America restated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.